Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500098764Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in indirect inguinal hernia (IIH) (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: ED50 and ED95 of ciprofol for suppressing tracheal intubation response. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500098764.